31/10/2025
Case report: Oral tofacitinib achieved rapid and sustained remission in cases of refractory thyroid eye disease, targeting proinflammatory cytokine pathways implicated in orbital fibroblast activation. https://ja.ma/47rc4BY
JAMA Ophthalmology is a member of the JAMA Network, a consortium of peer-reviewed publications.
Be the first to know and let us send you an email when JAMA Ophthalmology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to JAMA Ophthalmology:
Want your business to be the top-listed Media Company?